Cargando…

Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients

SUMMARIZING THE IMPORTANCE OF THE STUDY: The repetitive usage of gadolinium-based contrast agents (GBCA) is critical for magnetic resonance imaging (MRI) evaluation of tumor burden in glioblastoma patients. It is also a crucial tool for determination of radiographical response to treatment. GBCA inj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hattingen, Elke, Müller, Andreas, Jurcoane, Alina, Mädler, Burkhard, Ditter, Philip, Schild, Hans, Herrlinger, Ulrich, Glas, Martin, Kebir, Sied
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581129/ https://www.ncbi.nlm.nih.gov/pubmed/28881830 http://dx.doi.org/10.18632/oncotarget.18612

Ejemplares similares

Quantitative T1‐mapping detects cloudy‐enhancing tumor compartments predicting outcome of patients with glioblastoma
por: Müller, Andreas, et al.
Publicado: (2016)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Regorafenib in glioblastoma recurrence: how to deal with conflicting ‘real-life’ experiences?
por: Glas, Martin, et al.
Publicado: (2019)

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
por: Kebir, Sied, et al.
Publicado: (2016)

Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
por: Schäfer, Niklas, et al.
Publicado: (2019)

Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022
por: Oster, Christoph, et al.
Publicado: (2023)

A Comprehensive Introduction to Magnetic Resonance Imaging Relaxometry and Contrast Agents
por: Alzola-Aldamizetxebarria, Saioa, et al.
Publicado: (2022)

First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
por: Lazaridis, Lazaros, et al.
Publicado: (2022)

Central nervous system imaging in childhood Langerhans cell histiocytosis – a reference center analysis
por: Porto, Luciana, et al.
Publicado: (2015)

Quantitative MRI using relaxometry in malignant gliomas detects contrast enhancement in peritumoral oedema
por: Blystad, I., et al.
Publicado: (2020)

Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
por: Schmidt, Teresa, et al.
Publicado: (2023)

Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy
por: Kebir, Sied, et al.
Publicado: (2012)

Synthetic quantitative MRI through relaxometry modelling
por: Callaghan, Martina F., et al.
Publicado: (2016)

Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression
por: Lu, I-Na, et al.
Publicado: (2021)

Intracellular Relaxometry, Challenges, and Future Directions
por: Sigaeva, Alina, et al.
Publicado: (2022)

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study
por: Steidl, Eike, et al.
Publicado: (2016)

News on the horizon in glioblastoma therapy
por: Herrlinger, Ulrich
Publicado: (2020)

Relaxometry with Nitrogen Vacancy (NV) Centers in Diamond
por: Mzyk, Aldona, et al.
Publicado: (2022)

Efficiency analysis for quantitative MRI of T1 and T2 relaxometry methods
por: Leitão, David, et al.
Publicado: (2021)

Quantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan
Publicado: (2020)

The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T(1) relaxometry in patients with prostate cancer
por: Sushentsev, Nikita, et al.
Publicado: (2020)

Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy – An investigation of chelate stability using relaxometry
por: Mahmood, Faisal, et al.
Publicado: (2022)

Dynamics of Solid Proteins by Means of Nuclear Magnetic Resonance Relaxometry
por: Kruk, Danuta, et al.
Publicado: (2019)

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis
por: Gracien, René-Maxime, et al.
Publicado: (2016)

Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12
por: Giordano, Frank A., et al.
Publicado: (2019)

Automated Quantitative Relaxometry for Deep Neuromuscular Blockade in Robot-Assisted Prostatectomy
por: Sunnen, Michèle, et al.
Publicado: (2020)

The relaxometry hype cycle
por: Stikov, Nikola, et al.
Publicado: (2023)

Molecular Dynamics of Jelly Candies by Means of Nuclear Magnetic Resonance Relaxometry
por: Kruk, Danuta, et al.
Publicado: (2023)

Fast, Broad-Band Magnetic Resonance Spectroscopy with Diamond Widefield Relaxometry
por: Mignon, Charles, et al.
Publicado: (2023)

Methods for Dichoptic Stimulus Presentation in Functional Magnetic Resonance Imaging - A Review
por: Choubey, Bhaskar, et al.
Publicado: (2009)

Non-contrast T(1) and T(2) relaxometry characterizes reperfusion injury of acute MI in swine
por: Ding, Haiyan, et al.
Publicado: (2015)

Does radiation therapy increase gadolinium accumulation in the brain?: Quantitative analysis of T1 shortening using R1 relaxometry in glioblastoma multiforme patients
por: Lim, Woo Hyeon, et al.
Publicado: (2018)

Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma
por: Divé, Iris, et al.
Publicado: (2023)

MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease
por: Thrippleton, Michael J., et al.
Publicado: (2019)

Span of regularization for solution of inverse problems with application to magnetic resonance relaxometry of the brain
por: Bi, Chuan, et al.
Publicado: (2022)

Sample Shuttling Relaxometry of Contrast Agents: NMRD Profiles above 1 T with a Single Device
por: Gossuin, Yves, et al.
Publicado: (2016)

Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy
por: Hattingen, Elke, et al.
Publicado: (2013)

Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2020)

Correction to: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice
por: Shi, Wenyin, et al.
Publicado: (2021)

Validation of magnetic resonance relaxometry R2 value and cyst fluid iron level for diagnosis of ovarian endometrioma
por: Imanaka, Shogo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bdq1i9075cpob43p0ls1bsc7hk